The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages e1937–e1952,
https://doi.org/10.1210/clinem/dgaa982
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages 1325–1332, https://doi.org/10.1210/clinem/dgab070
Published: 09 February 2021
Context/objective
The aim of this study was to examine the effect of statins and other lipid-lowering agents on the development of Graves orbitopathy (GO) in patients with newly diagnosed Graves disease (GD).
Methods
Ya está disponible el vídeo de la reunión de Primavera SVEYDN en el área privada - enlace drive.
Matteo Spaziani, Chiara Tarantino, Natascia Tahani, Daniele Gianfrilli, Emilia Sbardella, Andrea M Isidori, Andrea Lenzi, Antonio F Radicioni
Frontiers in Endocrinology 2021, 12: 634288
Julian W Sacre, Dianna J Magliano, Jonathan E Shaw
Diabetes & Metabolism 2021 March 17, : 101249
Best Pract Res Clin Endocrinol Metab. 2021 Feb 6;101491.
PMID: 33593680